A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.

NCT00250367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder
Manic Disorder

Interventions

DRUG: risperidone

Sponsor

Janssen Pharmaceutica N.V., Belgium